![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Tag: Coronavirus information (COVID-19)
News
Oxford University Covid-19 vaccine raises hopes with strong trial results
Researchers at the University of Oxford believe they may have a breakthrough in their search for a Covid-19 vaccine after the team discovered that...
Clinical Trials
Moderna’s COVID-19 Vaccine Soon to Enter Phase 3 Trials as Phase 1 Shows Positive Results
Moderna, an American biotech company announced on July 14 that its COVID-19 vaccine candidate is finally going to enter the final phase on July...
Drug Research
CEPI expands partnership with Clover to rapidly advance development and manufacture of COVID-19 vaccine candidate
CEPI, the Coalition for Epidemic Preparedness Innovations, announced the expansion of its partnership with Sichuan Clover Biopharmaceuticals, Inc to rapidly advance the development and...
News
Gilead presents additional data on investigational antiviral remdesivir to treat COVID-19 at Virtual COVID-19 Conference
Gilead Sciences Inc, announced additional data on remdesivir, an investigational antiviral for the treatment of COVID-19, adding to the available body of knowledge on...
Drug Research
Biophore India gets DCGI nod to manufacture COVID drug Favipiravir API
Biophore India Pharmaceuticals, a Hyderabad-based firm, has received license from the Drug Controller General of India (DCGI) to manufacture Favipiravir, an active pharmaceutical ingredient...
Clinical Trials
Pfizer and BioNTech Granted FDA Fast Track Designation for Two Investigational mRNA-based Vaccine Candidates Against SARS-CoV-2
Pfizer Inc. and BioNTech SE announced that two of the companies’ four investigational vaccine candidates from their BNT162 mRNA-based vaccine program (BNT162b1 and BNT162b2)...
Press Releases
Biocon’s Breakthrough Drug Itolizumab Receives DCGI Nod for its Use in Moderate to Severe COVID-19 Patients
Biocon Ltd., an innovation-led global biopharmaceuticals company, announced that it has received the Drugs Controller General of India’s (DCGI) approval to market Itolizumab (ALZUMAb®)...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read